Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Castle Biosciences, Inc.ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's EsophagusStudies highlight how molecular risk assessment with TissueCypher can help inform surveillance and treatment decisions beyond biopsy findings alone — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative...
- Deadline Alert: HDFC Bank Limited (HDB) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitGlancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired HDFC Bank Limited (“HDFC” or the “Company”) (NYSE: HDB) securities between July 17, 2023 and May 26, 2026 inclusive (the “Class Period”).
- MedlineMedline launches enhanced TrackPoint™ to simplify inventory management for post-acute careCompanies: MedlineCombines real-time inventory tracking with PointClickCare® integration to reduce manual work and improve supply visibility — Medline (Nasdaq: MDLN) today announced the launch of an enhanced version of TrackPoint™, its online inventory...
- Equity Lifestyle Properties, Inc.Equity LifeStyle Properties, Inc. Announces Third Quarter 2026 Earnings Release And Conference CallEquity LifeStyle Properties, Inc. (NYSE: ELS) (referred to herein as the "Company," "we," "us," and "our") announced today that the Company's third quarter 2026 earnings will be released on Tuesday, October 20, 2026 after market close. The Company's...
- Danaher CorporationDanaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of DirectorsCompanies: Danaher CorporationDanaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today announced the appointment of Daniel L. Comas and Robert Hershberg, M.D., Ph.D., to the Danaher Board of Directors on October 9, 2026. Dr. Hershberg has also been appointed to the...
- Deadline Alert: Simply Good Foods Company (SMPL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitGlancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise Simply Good Foods Company (“Simply Good Foods” or the “Company”) (NASDAQ: SMPL) securities between October 24, 2024 and April 8, 2026 inclusive (the “Class Period”).
- Transocean Ltd. Announces Third Quarter 2026 Earnings Release DateTransocean Ltd. (NYSE: RIG) (“Transocean”) announced today that it will report earnings for the third quarter 2026 and issue a fleet status report on Monday, November 2, 2026, after the close of trading on the New York Stock Exchange.
- Par Pacific Holdings, Inc.Par Pacific Announces Third Quarter 2026 Earnings Release and Conference Call ScheduleCompanies: Par Pacific HoldingsPar Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that it will release its third quarter 2026 results after the New York Stock Exchange closes on Tuesday, November 3, 2026. This release will be followed by a conference call for investors on Wednesday, November 4, 2026, at 9:00 a.m. Central Time (10:00 a.m. Eastern). The full text of the release will be available on Par Pacific’s website at http://www.parpacific.com.
- Saga Communications, Inc.Saga Communications, Inc. Announces Date and Time of 3rd Quarter 2026 Earnings Release and Conference CallSaga Communications, Inc. (Nasdaq: SGA) announced today that it will release its 3rd Quarter 2026 Earnings results at 9:00 a.m. EST on Thursday, November 12, 2026. The company will be holding a conference call on the same date at 11:00 a.m. EST. The dial-in numbers are as follows:
- Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot UlcersOrganogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced the publication of previously released results from PREPARE1, a prospective, multicenter, randomized controlled trial (RCT) evaluating PuraPly®AM (PCMP) plus standard of care (SoC) compared to SoC alone in hard-to-heal diabetic foot ulcers (DFUs). The trial achieved its primary endpoint, and the results published in the Journal of Wound Care demonstrate statistically significant improvements in wound closure at 12 weeks among patients treated with PuraPly®AM plus SoC, providing clinical evidence supporting the use of PuraPly®AM in one of the most costly and difficult-to-treat chronic wound populations.
- Healthcare Realty Trust IncorporatedHealthcare Realty Trust Releases Eighth Corporate Responsibility ReportHealthcare Realty Trust Incorporated (NYSE: HR) today released its eighth annual Corporate Responsibility Report, highlighting the Company’s 2025 environmental, social, and governance (ESG) initiatives and accomplishments. The report outlines the Company’s progress toward its stated key performance indicators, environmental performance, and disclosures that align with the Task Force on Climate-Related Financial Disclosures (TCFD) and the Sustainability Accounting Standards Board (SASB).
- PROCEPT BioRoboticsPROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.